| NCT ID | NCT05073419 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Samir Saba |
| Condition | Acute Myocardial Infarction |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2022-08-09 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2022-08-09 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Patients post acute myocardial infarction (AMI) have a high risk of mortality but the use of an implantable defibrillator in the early aftermath of an AMI has not been shown to improve patients' survival. The VEST trial recently demonstrated an improved overall survival in post AMI patients with the use of a wearable defibrillator. The same improvement was not demonstrated for the risk of sudden cardiac death. Monitoring patients after AMI using an implantable cardiac monitor (ICM) may document findings that can impact patient management and eventually improve their outcomes. We are therefore conducting the AID MI trial to examine the impact of ICM on patient management in the post AMI setting.
Eligibility Criteria
Inclusion Criteria: * Adults, age 18 years or older * AMI (STEMI and NSTEMI) * Willing to give written informed consent * Expected discharge from hospital within 7 days of AMI * Willing to receive ICM insertion within 21 days of index AMI Exclusion Criteria: * Existing pacemaker, ICD, ICM, or any other implantable cardiac electronic device * Pregnant * Index AMI was more than 21 days * Unwilling/cannot insert ICM within 21 days post AMI * Planned ICD implant, planned CABG or any open-heart surgery (e.g. for severe valvular disease)
Contact & Investigator
Samir F Saba, MD
PRINCIPAL INVESTIGATOR
University of Pittsburgh Medical Center
Frequently Asked Questions
Who can join the NCT05073419 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Acute Myocardial Infarction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05073419 currently recruiting?
Yes, NCT05073419 is actively recruiting participants. Contact the research team at sabas@upmc.edu for enrollment information.
Where is the NCT05073419 trial being conducted?
This trial is being conducted at Pittsburgh, United States.
Who is sponsoring the NCT05073419 clinical trial?
NCT05073419 is sponsored by Samir Saba. The principal investigator is Samir F Saba, MD at University of Pittsburgh Medical Center. The trial plans to enroll 200 participants.